Introduction
Congenital anomaly (CA) is a defect in the morphogenesis of an organ that results from defective embryogenesis.1–3 CAs affect 1 in every 33 newborns.4 The global estimated prevalence of CAs is between 1% and 3% and varies widely among countries.2 5 6 Ninety-four percent of CAs occur in low and middle-income countries (LMICs) owing to high fertility rates, low pregnancy termination rates, nutritional deficiencies, increased intrauterine infections, and exposure to teratogens.7
For most CAs, the cause is not identified and is considered multifactorial, which accounts for as many as two-thirds of all defects.1 5 However, in most African cultures, superstitious beliefs dominate as the cause of these anomalies.6 Several risk factors have been attributed to the development of CAs. These include metabolic factors, such as hypothyroidism, uncontrolled diabetes, and maternal obesity.3 5 In addition, maternal exposures to certain drugs (trimethoprim, phenytoin, phenobarbitone and carbamazepine), infections (TORCHs—toxoplasmosis, others (syphilis, hepatitis B), rubella, cytomegalovirus (CMV) and herpes simplex) and radiation have been implicated.1 8 Similarly, maternal age (>35 years), family history of CAs, maternal history of CAs, high birth order (>4 births) and consanguineous marriage have been reported as significant risk factors for CAs.3 9 Preconceptual multivitamin supplements with folic acid at 400 mcg/day up to the 12th week of gestational age have been shown to reduce the rate of CAs.8
CAs contribute a significant proportion of infant mortality globally.4 10 It is estimated that they account for one-third of infant mortality, 8%–15% of perinatal deaths and 13%–16% of neonatal deaths.2 3 9 Globally, CAs are the fifth leading cause of death in children under 5 years of age, accounting for about 500 000 deaths annually, 97% of these occurring in LMICs.11 They account for about 9% of the surgical burden of diseases, and if left untreated, they contribute to the morbidity and mortality of 150 million children globally.11 They also account for a large number of cognitive and functional disabilities.1 The morbidity for untreated CAs is estimated at 57.7 million disability-adjusted life-years (DALYs) worldwide.12
Up to two-thirds of deaths and disabilities from CAs could be avoided by adequate surgical care.11 Significant advances in surgical management of CAs have resulted in treatment success in up to 90% of cases.4 In LMICs, these conditions are often left untreated owing to poor access to surgery, limited community awareness of potential treatment and stigmatization.12 Surgery is a cost-effective way to mitigate the significant premature mortality and lifelong disability from CAs.7 11
The overall prevalence and pattern of distribution of CAs in Tanzania remains unknown in literature. Several studies in Tanzania focusing on local regions have reported prevalence ranging from 0.28% to 6.05%, with the central nervous system (CNS) being the most common affected system throughout.13–15 The paucity of data on CAs is due to poor diagnostic capabilities in most health facilities, lack of awareness on management of CAs and absence of surveillance.13 This study was conducted with the aim of studying the distribution of various CAs among pediatric patients (under 5 years of age) who underwent corrective surgical treatment between 2017 and 2021.